Add-on Acquisition • Software

Revvity Acquires ACD/Labs

On November 10, 2025, Revvity acquired software company ACD/Labs

Acquisition Context

This is Revvity’s 4th transaction in the Software sector.
This is Revvity’s 2nd transaction in Canada.
This is Revvity’s 2nd transaction in Ontario.

Explore All 10283 Add-on Acquisition Software Deals - Search the Database Free

M&A Deal Summary
Date	November 10, 2025
Target	ACD/Labs
Sector	Software
Buyer(s)	Revvity
Deal Type	Add-on Acquisition

Target Company

ACD/Labs

Toronto, Ontario, Canada

ACD/Labs develops scientific informatics and cheminformatics software for research and development in the chemical, pharmaceutical, and materials industries. The Company’s products enable molecular modeling, analytical data management, and chemical property prediction, supporting workflows in areas such as NMR, mass spectrometry, and chromatography. ACD/Labs was founded in 1994 and is headquartered in Toronto, Ontario.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Revvity

Waltham, Massachusetts, United States

Category	Company
Founded	1937
Sector	Medical Products
Employees	11,000
Revenue	2.8B USD (2024)

DESCRIPTION

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formed in 1937 and is based in Waltham, Massachusetts.

Deal Context for Buyer	#
Overall	37 of 37
Sector: Software	4 of 4
Type: Add-on Acquisition	35 of 35
State: Ontario	2 of 2
Country: Canada	2 of 2
Year: 2025	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2022-08-01	PerkinElmer Shelton, Connecticut, United States PerkinElmer is a global analytics services and solutions provider for the biopharma, food, environmental, safety and applied end markets. The Company offers a comprehensive portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents, as well as laboratory services through the OneSource platform. PerkinElmer is based in Shelton, Connecticut.	Sell	$2.5B

DATE

TARGET

DEAL TYPE

VALUE

2022-08-01

PerkinElmer

Shelton, Connecticut, United States

PerkinElmer is a global analytics services and solutions provider for the biopharma, food, environmental, safety and applied end markets. The Company offers a comprehensive portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents, as well as laboratory services through the OneSource platform. PerkinElmer is based in Shelton, Connecticut.

Sell

$2.5B

Explore Related M&A Activity

Software M&A - Add-on Acquisition M&A Deals - Ontario M&A - Canada M&A - 2025 M&A